# Ascelia Pharma – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/ascelia-pharma
Company JSON: https://spela.port0.org/company/ascelia-pharma/company.json
Documents JSON: https://spela.port0.org/company/ascelia-pharma/documents.json
Updated: 2026-08-07T01:14:22Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/ascelia-pharma/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/ascelia-pharma/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/ascelia-pharma/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/ascelia-pharma/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/ascelia-pharma/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/ascelia-pharma/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/ascelia-pharma/reports
- JSON: https://spela.port0.org/company/ascelia-pharma/reports/reports.json
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=b69e833ef3fd325c14b44bfc91e2a9f2f&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=b09d01f06d38330f139cdb8b92b3580f2&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b8edbdd8cff5d787e93ebd817fa866254&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b4c0ac7b24fd0b3e05b58b7113c01f556&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b4e2b23a5f5fff25b28ac4cadfe8da712&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b9ea9b36d4b231c94af03a4b9d924ff90&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b0f00ac372dd574182515b9261b30e206&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b3632030a6629982bd17878b9cb9d4115&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=bc21dfc30d3540aeb444935f06e6972d2&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=b4956867fb8f131ceadffce5286183d8b&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=bdf1b0389fdef135169b56502e24911a1&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=bda2a301b6d24ae2e9bff4ed8c3672a23&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=bc37e6c44f6bae3b8eee4a241226664ea&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=be1dbee39a2436abecbee0763eee739d4&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b699d093efd0878ee0e9cad791c2bca65&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b4f9bfcf2b2288a03455413497a756177&lang=sv&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/ascelia-pharma/finansinspektionen
- Summary: https://spela.port0.org/company/ascelia-pharma/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/ascelia-pharma/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/ascelia-pharma/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/ascelia-pharma/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/ascelia-pharma/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/ascelia-pharma/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/ascelia-pharma/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt